Triple-negative breast cancer (TNBC), lacking the expression of receptors for estrogen and progesterone (ER and PR, respectively) and a growth factor (HER2/ErbB2), is a highly aggressive subtype of breast cancer with poor prognosis and limited options for targeted therapies. The gene discussed is ERBB2; the disease is breast carcinoma.